Brief: Onesource Specialty Says Onesource-Hikma Secures Approval To Commercialise Generic Ozempic In Saudi Arabia
11/02/2026 02:52
Feb 11 (Reuters) - Onesource Specialty Pharma Ltd ONEO.NS: ONESOURCE SPECIALTY - ONESOURCE-HIKMA SECURES APPROVAL TO COMMERCIALISE GENERIC OZEMPIC IN SAUDI ARABIA Source text: ID:nBSE8SwyPY Further company coverage: ONEO.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Onesource Specialty Pharma
See all newsIndia's Onesource Specialty Pharma rises most in 2-1/2 months on quarterly profit
Brief: Onesource Specialty Pharma June-Quarter Consol PAT 250 Million Rupees
Brief: Onesource Specialty Pharma Says Co, Formycon AG Announce Strategic Manufacturing Partnership For Biosimilars
Brief: Onesource Specialty Pharma Says Delay In Dr Reddy's Supplies Does Not Materially Impact Co's Operations
Brief: Onesource Specialty Pharma Says USFDA Conducts Routine CGMP Inspection At Onesource SPD Bengaluru